|
|
| Line 1: |
Line 1: |
| {{Infobox medical condition (new) | | {{Short description|A type of brain tumor}} |
| | name = Dysembryoplastic neuroepithelial tumour
| | {{Use dmy dates|date=October 2023}} |
| | image = DNET HE.jpg
| |
| | caption = DNET
| |
| | pronounce =
| |
| | field = [[Neurosurgery]]
| |
| | synonyms =
| |
| | symptoms =
| |
| | complications =
| |
| | onset =
| |
| | duration =
| |
| | types =
| |
| | causes =
| |
| | risks = | |
| | diagnosis =
| |
| | differential =
| |
| | prevention =
| |
| | treatment =
| |
| | medication =
| |
| | prognosis =
| |
| | frequency =
| |
| | deaths =
| |
| }}
| |
| '''Dysembryoplastic neuroepithelial tumour''' ('''DNT''', '''DNET''') is a type of [[Brain tumour|brain tumor]]. Most commonly found in the [[temporal lobe]], DNTs have been classified as [[Benign tumor|benign]] tumours.<ref name=":0">{{Cite journal|last=Thom|first=Maria|last2=Toma|first2=Ahmed|last3=An|first3=Shu|last4=Martinian|first4=Lillian|last5=Hadjivassiliou|first5=George|last6=Ratilal|first6=Bernardo|last7=Dean|first7=Andrew|last8=McEvoy|first8=Andrew|last9=Sisodiya|first9=Sanjay M.|date=2011-10-01|title=One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature|journal=Journal of Neuropathology and Experimental Neurology|volume=70|issue=10|pages=859–878|doi=10.1097/NEN.0b013e3182302475|issn=1554-6578|pmid=21937911|doi-access=free}}</ref> These are glioneuronal tumours comprising both [[Neuroglia|glial]] and [[neuron]] cells and often have ties to [[Cortical dysplasia|focal cortical dysplasia]].<ref name=":1">{{Cite journal|last=Suh|first=Yeon-Lim|date=2015-11-01|title=Dysembryoplastic Neuroepithelial Tumors|journal=Journal of Pathology and Translational Medicine|volume=49|issue=6|pages=438–449|doi=10.4132/jptm.2015.10.05|issn=2383-7837|pmc=4696533|pmid=26493957}}</ref>
| |
|
| |
|
| Varying subclasses of DNTs have been presently identified, with dispute existing in the field on how to properly group these classes.<ref name=":2">{{Cite journal|last=Komori|first=Takashi|last2=Arai|first2=Nobutaka|date=2013-08-01|title=Dysembryoplastic neuroepithelial tumor, a pure glial tumor? Immunohistochemical and morphometric studies|journal=Neuropathology|language=en|volume=33|issue=4|pages=459–468|doi=10.1111/neup.12033|pmid=23530928|issn=1440-1789}}</ref> The identification of possible genetic markers to these tumours is currently underway.<ref name=":3">{{Cite journal|last=Chassoux|first=Francine|last2=Daumas-Duport|first2=Catherine|date=2013-12-01|title=Dysembryoplastic neuroepithelial tumors: Where are we now?|journal=Epilepsia|language=en|volume=54|pages=129–134|doi=10.1111/epi.12457|issn=1528-1167|pmid=24328886}}</ref> With DNTs often causing epileptic seizures, surgical removal is a common treatment, providing high rates of success.<ref name=":3" />
| | '''Dysembryoplastic neuroepithelial tumour''' (DNET) is a rare, benign brain tumor that is typically associated with [[epilepsy]]. It is classified as a [[glioneuronal tumor]], which means it contains both glial and neuronal elements. DNETs are most commonly found in children and young adults and are often located in the [[cerebral cortex]], particularly in the [[temporal lobe]]. |
|
| |
|
| == Signs and symptoms == | | ==Pathophysiology== |
| Seizures and [[epilepsy]] are the strongest ties to dysembryoplastic neuroepithelial tumours.<ref name=":3" /> The most common symptom of DNTs are [[Partial seizure|complex partial seizures]].<ref name=":1" /> Simple DNTs more frequently manifest [[generalized seizures]].<ref name=":1" /> In children, DNTs are considered to be the second leading cause of epilepsy.<ref name=":2" /> A headache is another common symptom.<ref name=":1" /> Other neurological impairments besides seizures are not common.<ref name=":1" />
| | DNETs are thought to arise from abnormal development of the [[neuroepithelium]], the tissue that gives rise to the [[central nervous system]]. These tumors are characterized by a specific histological pattern, which includes the presence of "floating neurons" in a myxoid background and columns of glial cells. The exact cause of DNETs is not well understood, but they are considered to be developmental lesions rather than true neoplasms. |
|
| |
|
| == Pathogenesis == | | ==Clinical Presentation== |
| Dysembryoplastic neuroepithelial tumours are largely glioneuronal tumours, meaning they are composed of both [[Neuroglia|glial]] cells and [[neuron]]s.<ref name=":1" />
| | Patients with DNETs typically present with [[seizures]], which are often the first and only symptom. The seizures are usually focal and may be resistant to [[antiepileptic drugs]]. Other symptoms depend on the tumor's location and may include [[headaches]], [[nausea]], or [[neurological deficits]]. |
|
| |
|
| Three subunits of DNTs have been commonly identified:<ref name=":1" />
| | ==Diagnosis== |
| * Simple: Specific glioneuronal elements are the sole components of simple DNTs.<ref name=":1" />
| | The diagnosis of DNET is primarily based on [[magnetic resonance imaging]] (MRI) findings and histological examination. On MRI, DNETs appear as well-circumscribed, cortical lesions that may have a "bubbly" appearance due to their cystic components. [[Computed tomography]] (CT) scans may show a hypodense lesion without significant enhancement. Definitive diagnosis is made through [[biopsy]] and histopathological analysis. |
| * Complex: Glial nodules and/or type 3b [[Cortical dysplasia|focal cortical dysplasia]] (FCD), in addition to the glioneuronal elements are present in complex DNTs.<ref name=":3" /> Both the nodules and FCD can be present within the same tumour, though only 47% of complex DNTs are linked to FCD.<ref name=":1" />
| |
| * Nonspecific: Nonspecific DNTs are lacking the glioneuronal elements common to DNTs but will show glial nodules and/or type 3b FCD.<ref name=":1" /> Eighty-five percent of nonspecific case of DNTs show this FCD.<ref name=":1" />
| |
| There currently exists some debate over where to make the proper division for the subunits of DNTs. A fourth subunit is sometimes noted as a mixed subunit. This mixed subunit expresses the glial nodules and components of [[ganglioglioma]].<ref name=":0" /> Other findings suggest that DNTs require a reclassification to associate them with [[Oligodendroglioma|oligodendrogliomas]], tumours that arise from solely glial cells.<ref name=":2" /> These reports suggest that the neurons found within DNTs are much rarer than previously reported. For the neurons that are seen in the tumours, it is suggested that they had been trapped within the tumor upon formation, and are not a part of the tumour itself.<ref name=":2" />
| |
|
| |
|
| == Diagnosis == | | ==Treatment== |
| [[File:DNET02.jpg|thumb|Dysembryoplastic neuroepithelial tumour, MRI FLAIR.]]
| | The primary treatment for DNET is surgical resection. Complete removal of the tumor often results in seizure control and is considered curative. In cases where the tumor cannot be completely resected, additional treatments such as [[antiepileptic drugs]] or [[vagus nerve stimulation]] may be used to manage seizures. Radiation therapy and chemotherapy are generally not indicated due to the benign nature of the tumor. |
| A dysembryoplastic neuroepithelial tumour is commonly diagnosed in patients who are experiencing seizures with [[magnetic resonance imaging]] (MRI), [[electroencephalogram]] (EEG).<ref name=":3" /> A DNT is most commonly diagnosed in children who are experiencing seizures, and when given medication do not respond to them. When an MRI is taken there are lesions located in the temporal parietal region of the brain.<ref name=":3" />
| |
|
| |
|
| Typical DNTs can be detected in an EEG scan when there are rapid repetitive spikes against a contrasted background.<ref name=":3" /> EEG are predominantly localized with DNT location in the brain, however there are nonspecific cases in which the location of the tumour is abnormal and not localized.<ref name=":3" />
| | ==Prognosis== |
| === Classification ===
| | The prognosis for patients with DNET is generally excellent, especially when the tumor is completely resected. Most patients experience significant improvement in seizure control post-surgery. The risk of malignant transformation is extremely low, and long-term survival rates are high. |
| Dysembryoplastic neuroepithelial tumours are classified as a benign tumour, Grade I of the [[World Health Organization]] (WHO) classification of brain tumours.<ref name=":0" /> This classification by WHO only covers the simple and complex subunits. Groups lacking glioneuronal elements were not considered to have fallen in the same group and have thusly not yet been classified.<ref name=":0" />
| |
|
| |
|
| === Complications in diagnosis === | | ==Related pages== |
| Dysembryoplastic neuroepithelial tumours are often described as a low grade tumour because about 1.2% people under the age of twenty are affected and about 0.2% over the age of twenty are affected by this tumour.<ref name=":4">{{Cite journal|last=Shen|first=JunK|last2=Guduru|first2=Harsha|last3=Lokannavar|first3=HarishS|date=2012-01-01|title=A Rare Case of Dysembryoplastic Neuroepithelial Tumor|url=http://www.clinicalimagingscience.org/text.asp?2012/2/1/60/102057|journal=Journal of Clinical Imaging Science|language=en|volume=2|issue=1|doi=10.4103/2156-7514.102057|pmc=3515966|pmid=23230542|page=60}}</ref> Since its prevalence is small among the population, it often goes misdiagnosed or even at times goes undiagnosed.
| | * [[Epilepsy]] |
| | * [[Glioneuronal tumor]] |
| | * [[Neuroepithelium]] |
| | * [[Seizure]] |
| | * [[Magnetic resonance imaging]] |
|
| |
|
| == Treatment ==
| | [[Category:Brain tumors]] |
| The most common course of treatment of DNT is surgery. About 70-90% of surgery are successful in removing the tumour.<ref name=":3" /> Since the tumour is most often benign, and does not impose immediate threat, aggressive treatments such as [[chemotherapy]] and radiation are not needed, and therefore patients especially children and young adults do not have to go through the side effects of these treatments.<ref name=":4" />
| | [[Category:Epilepsy]] |
| | | [[Category:Neuroepithelial tumors]] |
| In order for the seizures to completely be stopped the tumour needs to be completely removed. For the tumor to be completely removed doctors need to perform resections consisting an [[anterior temporal lobectomy]] or [[Amygdalohippocampectomy|amygdalo-hippocampectomy]].<ref name=":3" /> It has been found that if the tumour is removed by performing resections patients are then recognized as seizure free. On the other hand, if resections are not performed, and the tumour is not completely removed, then the patient is still at risk of experiencing the seizures.<ref name=":3" /> In a study done by Bilginer et al., 2009, looking at patients whose tumour was not completely removed, and saw that they were still experiencing seizures, concluding that the incomplete resection as a being a failure.<ref name=":3" /> This then causes the patient to undergo a second surgery and remove the tumour in which case causing a complete resection.
| |
| | |
| == Outcomes ==
| |
| Recurrence of the tumour is highly unlikely if the patient undergoes a complete resection since the tumour is completely taken out.<ref name=":4" /> Most of the tumours observed in patients are benign tumours, and once taken out do not cause neurological deficits. However, there have been incidents where the tumour was malignant.<ref name=":4" /> There have been cases where the malignant tumour has made a reoccurrence, and this happens at the site of the residual tumour in which an incomplete resection has been done.<ref name=":3" /> In this case, a second operation has to be done in order to completely remove the malignant tumour. In a study done with Daumas Duport and Varlet, 2003, they have found that there has been one case so far that the tumour has come back, however, in that particular case the patient underwent an incomplete resection, which led them to perform a second surgery in order to remove it completely.<ref name=":3" /> This evidence shows that surgery and complete resections are one of the better approaches in treating dysembryoplastic neuroepithelial tumours.
| |
| | |
| Furthermore, a longer period of epilepsy, and patients older in age are less likely to have a full recovery and remain seizure free. This is the case because their body is not able to recover as quickly, as it would for a child who has had one seizure before.<ref name=":4" /> Therefore, it is crucial to diagnose and perform the surgery early in order to make a full recovery.
| |
| | |
| == Epidemiology ==
| |
| Children are much more prone to exhibit these dysembryoplastic neuroepithelial tumours than adults.<ref name=":0" /> The mean age of onset of seizures for children with DNTs is 8.1 years old.<ref name=":0" /> Few other neurological deficits are associated with DNTs, so that earlier detection of the tumour before seizure symptoms are rare.<ref name=":1" /> DNTs are found in the [[temporal lobe]] in 84% of reported cases.<ref name=":0" /> In children, DNTs account for 0.6% of diagnosed [[central nervous system]] tumours.<ref name=":1" /> It has been found that males have a slightly higher risk of having these tumours.<ref name=":1" /> Some familial accounts of DNTs have been documented, though the genetic ties have not yet been fully confirmed.<ref name=":1" />
| |
| | |
| == History ==
| |
| Dysembryoplastic neuroepithelial tumours were usually found during investigation of patients who underwent multiple seizures.<ref name=":1" /> The tumours were encountered when the patient required surgery to help with the epilepsy to help with the seizures. The term DNT was first introduced in 1988 by Daumas-Duport, terming it dysembryoplastic, suggesting a dysembryoplastic origin in early onset seizures, and neuroepithelial to allow the wide range of possible varieties of tumours to be put into the category.<ref name=":1" /> In 2003 and 2007, DNT was made into further subsets of categories based upon the displayed elements within the tumour.<ref name=":1" />
| |
| | |
| ==See also==
| |
| *[[Pilocytic astrocytoma]]
| |
| *[[Oligodendroglioma]]
| |
| *[[Cortical dysplasia|Focal cortical dysplasia]]
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| == External links ==
| |
| {{Medical resources
| |
| | DiseasesDB =
| |
| | ICD10 =
| |
| | ICD9 =
| |
| | ICDO = 9413/0
| |
| | OMIM =
| |
| | MedlinePlus =
| |
| | eMedicineSubj =
| |
| | eMedicineTopic =
| |
| | MeshID =
| |
| }}
| |
| | |
| {{Nervous tissue tumors}}
| |
| | |
| [[Category:Brain tumor]] | |
| {{dictionary-stub1}}
| |
A type of brain tumor
Dysembryoplastic neuroepithelial tumour (DNET) is a rare, benign brain tumor that is typically associated with epilepsy. It is classified as a glioneuronal tumor, which means it contains both glial and neuronal elements. DNETs are most commonly found in children and young adults and are often located in the cerebral cortex, particularly in the temporal lobe.
Pathophysiology
DNETs are thought to arise from abnormal development of the neuroepithelium, the tissue that gives rise to the central nervous system. These tumors are characterized by a specific histological pattern, which includes the presence of "floating neurons" in a myxoid background and columns of glial cells. The exact cause of DNETs is not well understood, but they are considered to be developmental lesions rather than true neoplasms.
Clinical Presentation
Patients with DNETs typically present with seizures, which are often the first and only symptom. The seizures are usually focal and may be resistant to antiepileptic drugs. Other symptoms depend on the tumor's location and may include headaches, nausea, or neurological deficits.
Diagnosis
The diagnosis of DNET is primarily based on magnetic resonance imaging (MRI) findings and histological examination. On MRI, DNETs appear as well-circumscribed, cortical lesions that may have a "bubbly" appearance due to their cystic components. Computed tomography (CT) scans may show a hypodense lesion without significant enhancement. Definitive diagnosis is made through biopsy and histopathological analysis.
Treatment
The primary treatment for DNET is surgical resection. Complete removal of the tumor often results in seizure control and is considered curative. In cases where the tumor cannot be completely resected, additional treatments such as antiepileptic drugs or vagus nerve stimulation may be used to manage seizures. Radiation therapy and chemotherapy are generally not indicated due to the benign nature of the tumor.
Prognosis
The prognosis for patients with DNET is generally excellent, especially when the tumor is completely resected. Most patients experience significant improvement in seizure control post-surgery. The risk of malignant transformation is extremely low, and long-term survival rates are high.
Related pages
